Literature DB >> 27425813

Targeting PADI2 could stop the progression of myeloma.

Sanjay Tanday.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27425813     DOI: 10.1016/S1470-2045(16)30314-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  5 in total

Review 1.  Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.

Authors:  Wubin Zheng; Fan Wu; Kai Fu; Guangshun Sun; Guoqiang Sun; Xiao Li; Wei Jiang; Hongyong Cao; Hanjin Wang; Weiwei Tang
Journal:  Onco Targets Ther       Date:  2021-05-06       Impact factor: 4.147

2.  Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.

Authors:  Wei Guo; Yabing Zheng; Bing Xu; Fang Ma; Chang Li; Xiaoqian Zhang; Yao Wang; Xiaotian Chang
Journal:  Onco Targets Ther       Date:  2017-03-08       Impact factor: 4.147

3.  The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.

Authors:  Dong Chen; Qiang Sun; Lufei Zhang; Xiaohu Zhou; Xiaofei Cheng; Dongkai Zhou; Feng Ye; Jianjiang Lin; Weilin Wang
Journal:  Oncotarget       Date:  2017-08-03

Review 4.  Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer.

Authors:  Miguel Beato; Priyanka Sharma
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 6.208

5.  Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.

Authors:  Lidong Liu; Zhiwei Zhang; Guoxiang Zhang; Ting Wang; Yingchun Ma; Wei Guo
Journal:  J Transl Med       Date:  2020-09-20       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.